Inventor · London, GB

Peter Rands

14Patents

6h-index

15Co-inventors

55Inventor score

Filing activity: Jul 31, 2018 → Mar 31, 2023

Most-cited inventions

Patent	Title	Area	Cited by	Status
US11471417B2	Deuterated N,N-dimethyltryptamine compounds	Chemistry; Metallurgy	14	Active
US11660289B2	Deuterated or partially deuterated N,N-dimethyltryptamine compounds	Chemistry; Metallurgy	9	Active
US11697638B2	5-methoxy-N,N-dimethyltryptamine crystalline forms	Chemistry; Metallurgy	9	Active
US11773062B2	Deuterated compounds	Chemistry; Metallurgy	8	Active
US11643390B2	Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses	Chemistry; Metallurgy	8	Active
US11578039B2	Compounds	Chemistry; Metallurgy	8	Active
US11771681B2	Therapeutic compounds	Chemistry; Metallurgy	1	Active
US12157723B2	Compounds	Chemistry; Metallurgy	0	Active
US11377416B2	Crystalline forms of hydroxynorketamine	Chemistry; Metallurgy	0	Active
US12076311B2	Therapeutic compositions comprising deuterated or partially deuterated N,N-dimethyltryptamine compounds	Chemistry; Metallurgy	0	Active
US12084417B2	Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses	Chemistry; Metallurgy	0	Active
US12042564B2	Therapeutic solid dosage forms	Chemistry; Metallurgy	0	Active
US12318477B2	Injectable and inhalable formulations	Human Necessities	0	Active
US12251371B2	Deuterated or partially deuterated N,N-dimethyltryptamine compounds	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.